Overview

A Study to Assess the Safety and Efficacy of Alefacept in Kidney Transplant Recipients

Status:
Completed
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
A study to assess the safety and efficacy of Alefacept in de novo kidney transplant patients.
Phase:
Phase 2
Details
Lead Sponsor:
Astellas Pharma Inc
Treatments:
Alefacept
Antibodies, Monoclonal
Basiliximab
Mycophenolate mofetil
Mycophenolic Acid
Tacrolimus